127 related articles for article (PubMed ID: 15628641)
1. Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacy.
Stummvoll GH; Aringer M; Jansen M; Smolen JS; Derfler K; Graninger WB
Wien Klin Wochenschr; 2004 Nov; 116(21-22):716-24. PubMed ID: 15628641
[TBL] [Abstract][Full Text] [Related]
2. Rapid reduction of antibodies and improvement of disease activity by immunoadsorption in Chinese patients with severe systemic lupus erythematosus.
Huang J; Song G; Yin Z; He W; Zhang L; Kong W; Ye Z
Clin Rheumatol; 2016 Sep; 35(9):2211-8. PubMed ID: 27488202
[TBL] [Abstract][Full Text] [Related]
3. Immunoadsorption (IAS) for systemic lupus erythematosus.
Stummvoll GH
Lupus; 2011 Feb; 20(2):115-9. PubMed ID: 21303827
[TBL] [Abstract][Full Text] [Related]
4. Immunoadsorption for systemic lupus erythematosus.
Stummvoll GH; Julius U; Derfler K; Aringer M
Atheroscler Suppl; 2009 Dec; 10(5):110-3. PubMed ID: 20129387
[TBL] [Abstract][Full Text] [Related]
5. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
[TBL] [Abstract][Full Text] [Related]
6. IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study.
Stummvoll GH; Aringer M; Smolen JS; Schmaldienst S; Jiménez-Boj E; Hörl WH; Graninger WB; Derfler K
Ann Rheum Dis; 2005 Jul; 64(7):1015-21. PubMed ID: 15640267
[TBL] [Abstract][Full Text] [Related]
7. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus.
Braun N; Erley C; Klein R; Kötter I; Saal J; Risler T
Nephrol Dial Transplant; 2000 Sep; 15(9):1367-72. PubMed ID: 10978392
[TBL] [Abstract][Full Text] [Related]
8. Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity.
Stummvoll GH; Schmaldienst S; Smolen JS; Derfler K; Biesenbach P
Nephrol Dial Transplant; 2012 Feb; 27(2):618-26. PubMed ID: 21617196
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review.
Kronbichler A; Brezina B; Quintana LF; Jayne DR
Autoimmun Rev; 2016 Jan; 15(1):38-49. PubMed ID: 26318215
[TBL] [Abstract][Full Text] [Related]
10. Immunoadsorption therapy (therasorb) in patients with severe lupus erythematosus.
Graninger M; Schmaldienst S; Derfler K; Graninger WB
Acta Med Austriaca; 2002; 29(1):26-9. PubMed ID: 11899750
[TBL] [Abstract][Full Text] [Related]
11. Severe infections in plasmapheresis-treated systemic lupus erythematosus.
Aringer M; Smolen JS; Graninger WB
Arthritis Rheum; 1998 Mar; 41(3):414-20. PubMed ID: 9506568
[TBL] [Abstract][Full Text] [Related]
12. Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome.
Gulati S; Pokhariyal S; Sharma RK; Elhence R; Kher V; Pandey CM; Gupta A
Nephrol Dial Transplant; 2001 Oct; 16(10):2013-7. PubMed ID: 11572890
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy comparison of HA280 and DNA280 immunoadsorption column in treating systemic lupus erythematosus.
Xu L; Wu X; Zou Y
Mod Rheumatol; 2016; 26(1):94-8. PubMed ID: 26025438
[TBL] [Abstract][Full Text] [Related]
14. Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy.
Opastirakul S; Chartapisak W
Pediatr Nephrol; 2005 Dec; 20(12):1750-5. PubMed ID: 16133037
[TBL] [Abstract][Full Text] [Related]
15. Intravenous pulse cyclophosphamide therapy in focal segmental glomerulosclerosis.
Buyukcelik M; Cengiz N; Dursun H; Soran M; Bayazit AK; Noyan A; Anarat A
Clin Nephrol; 2006 Jan; 65(1):7-12. PubMed ID: 16429836
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A and therapeutic plasma exchange in the treatment of severe systemic lupus erythematosus.
Bambauer R; Schwarze U; Schiel R
Artif Organs; 2000 Nov; 24(11):852-6. PubMed ID: 11119071
[TBL] [Abstract][Full Text] [Related]
17. Immunoadsorption in Autoimmune Diseases Affecting the Kidney.
Stummvoll G; Aringer M; Handisurya A; Derfler K
Semin Nephrol; 2017 Sep; 37(5):478-487. PubMed ID: 28863794
[TBL] [Abstract][Full Text] [Related]
18. Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis.
Gulati S; Kher V
Indian Pediatr; 2000 Feb; 37(2):141-8. PubMed ID: 10745408
[TBL] [Abstract][Full Text] [Related]
19. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome.
Kahl LE
J Rheumatol; 1994 Jan; 21(1):84-6. PubMed ID: 8151595
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.
Terrier B; Amoura Z; Ravaud P; Hachulla E; Jouenne R; Combe B; Bonnet C; Cacoub P; Cantagrel A; de Bandt M; Fain O; Fautrel B; Gaudin P; Godeau B; Harlé JR; Hot A; Kahn JE; Lambotte O; Larroche C; Léone J; Meyer O; Pallot-Prades B; Pertuiset E; Quartier P; Schaerverbeke T; Sibilia J; Somogyi A; Soubrier M; Vignon E; Bader-Meunier B; Mariette X; Gottenberg JE;
Arthritis Rheum; 2010 Aug; 62(8):2458-66. PubMed ID: 20506527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
